Calcium in PDB 1ing: Influenza A Subtype N2 Neuraminidase Complexed with Aromatic BANA109 Inhibitor
Enzymatic activity of Influenza A Subtype N2 Neuraminidase Complexed with Aromatic BANA109 Inhibitor
All present enzymatic activity of Influenza A Subtype N2 Neuraminidase Complexed with Aromatic BANA109 Inhibitor:
3.2.1.18;
Protein crystallography data
The structure of Influenza A Subtype N2 Neuraminidase Complexed with Aromatic BANA109 Inhibitor, PDB code: 1ing
was solved by
M.J.Jedrzejas,
M.Luo,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
6.50 /
2.40
|
Space group
|
C 2 2 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
119.420,
139.060,
139.620,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
16.3 /
n/a
|
Calcium Binding Sites:
The binding sites of Calcium atom in the Influenza A Subtype N2 Neuraminidase Complexed with Aromatic BANA109 Inhibitor
(pdb code 1ing). This binding sites where shown within
5.0 Angstroms radius around Calcium atom.
In total 2 binding sites of Calcium where determined in the
Influenza A Subtype N2 Neuraminidase Complexed with Aromatic BANA109 Inhibitor, PDB code: 1ing:
Jump to Calcium binding site number:
1;
2;
Calcium binding site 1 out
of 2 in 1ing
Go back to
Calcium Binding Sites List in 1ing
Calcium binding site 1 out
of 2 in the Influenza A Subtype N2 Neuraminidase Complexed with Aromatic BANA109 Inhibitor
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 1 of Influenza A Subtype N2 Neuraminidase Complexed with Aromatic BANA109 Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca470
b:37.8
occ:1.00
|
OE1
|
A:GLN347
|
1.5
|
12.7
|
1.0
|
O
|
A:ASP293
|
1.7
|
11.2
|
1.0
|
O
|
A:GLN347
|
2.0
|
23.8
|
1.0
|
O
|
A:GLY345
|
2.1
|
13.4
|
1.0
|
O
|
A:GLY297
|
2.4
|
15.0
|
1.0
|
CD
|
A:GLN347
|
2.6
|
20.8
|
1.0
|
C
|
A:ASP293
|
3.0
|
14.7
|
1.0
|
C
|
A:GLN347
|
3.1
|
21.1
|
1.0
|
C
|
A:GLY345
|
3.2
|
16.8
|
1.0
|
OD2
|
A:ASP324
|
3.3
|
17.9
|
1.0
|
H
|
A:GLN347
|
3.3
|
15.0
|
1.0
|
H
|
A:GLY297
|
3.4
|
15.0
|
1.0
|
NE2
|
A:GLN347
|
3.5
|
23.2
|
1.0
|
N
|
A:GLN347
|
3.6
|
23.4
|
1.0
|
C
|
A:GLY297
|
3.6
|
19.8
|
1.0
|
HE21
|
A:GLN347
|
3.6
|
15.0
|
1.0
|
CG
|
A:GLN347
|
3.6
|
23.2
|
1.0
|
CA
|
A:GLY345
|
3.7
|
17.8
|
1.0
|
N
|
A:ASN294
|
3.8
|
18.6
|
1.0
|
CA
|
A:ASN294
|
3.8
|
21.0
|
1.0
|
CA
|
A:GLN347
|
3.9
|
22.4
|
1.0
|
H
|
A:ASP293
|
4.0
|
15.0
|
1.0
|
N
|
A:GLY348
|
4.0
|
16.4
|
1.0
|
CG
|
A:ASP324
|
4.0
|
17.3
|
1.0
|
CA
|
A:ASP293
|
4.1
|
11.6
|
1.0
|
C
|
A:ASN294
|
4.1
|
22.9
|
1.0
|
CB
|
A:GLN347
|
4.2
|
23.5
|
1.0
|
N
|
A:GLY297
|
4.2
|
27.2
|
1.0
|
CA
|
A:GLY348
|
4.2
|
11.1
|
1.0
|
OD1
|
A:ASP293
|
4.3
|
2.0
|
1.0
|
HE22
|
A:GLN347
|
4.3
|
15.0
|
1.0
|
N
|
A:THR346
|
4.3
|
17.0
|
1.0
|
CB
|
A:ASP293
|
4.3
|
8.4
|
1.0
|
C
|
A:THR346
|
4.4
|
23.2
|
1.0
|
N
|
A:ASP293
|
4.5
|
16.2
|
1.0
|
CA
|
A:GLY297
|
4.5
|
21.3
|
1.0
|
OD1
|
A:ASP324
|
4.5
|
14.4
|
1.0
|
N
|
A:TRP295
|
4.5
|
24.9
|
1.0
|
O
|
A:ASN294
|
4.5
|
22.5
|
1.0
|
N
|
A:SER298
|
4.6
|
18.4
|
1.0
|
H
|
A:TRP295
|
4.6
|
15.0
|
1.0
|
CA
|
A:THR346
|
4.7
|
21.2
|
1.0
|
H
|
A:ASN294
|
4.7
|
15.0
|
1.0
|
CA
|
A:SER298
|
4.7
|
13.7
|
1.0
|
CG
|
A:ASP293
|
4.8
|
5.5
|
1.0
|
N
|
A:GLY345
|
4.9
|
19.6
|
1.0
|
H
|
A:GLY348
|
4.9
|
15.0
|
1.0
|
O
|
A:ARG344
|
4.9
|
16.4
|
1.0
|
CB
|
A:ASP324
|
5.0
|
15.8
|
1.0
|
|
Calcium binding site 2 out
of 2 in 1ing
Go back to
Calcium Binding Sites List in 1ing
Calcium binding site 2 out
of 2 in the Influenza A Subtype N2 Neuraminidase Complexed with Aromatic BANA109 Inhibitor
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 2 of Influenza A Subtype N2 Neuraminidase Complexed with Aromatic BANA109 Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca470
b:37.8
occ:1.00
|
OE1
|
B:GLN347
|
1.5
|
12.7
|
1.0
|
O
|
B:ASP293
|
1.7
|
11.2
|
1.0
|
O
|
B:GLN347
|
2.0
|
23.8
|
1.0
|
O
|
B:GLY345
|
2.1
|
13.4
|
1.0
|
O
|
B:GLY297
|
2.4
|
15.0
|
1.0
|
CD
|
B:GLN347
|
2.6
|
20.8
|
1.0
|
C
|
B:ASP293
|
3.0
|
14.7
|
1.0
|
C
|
B:GLN347
|
3.1
|
21.1
|
1.0
|
C
|
B:GLY345
|
3.2
|
16.8
|
1.0
|
OD2
|
B:ASP324
|
3.3
|
17.9
|
1.0
|
H
|
B:GLN347
|
3.3
|
15.0
|
1.0
|
H
|
B:GLY297
|
3.4
|
15.0
|
1.0
|
NE2
|
B:GLN347
|
3.5
|
23.2
|
1.0
|
N
|
B:GLN347
|
3.6
|
23.4
|
1.0
|
C
|
B:GLY297
|
3.6
|
19.8
|
1.0
|
HE21
|
B:GLN347
|
3.6
|
15.0
|
1.0
|
CG
|
B:GLN347
|
3.6
|
23.2
|
1.0
|
CA
|
B:GLY345
|
3.7
|
17.8
|
1.0
|
N
|
B:ASN294
|
3.8
|
18.6
|
1.0
|
CA
|
B:ASN294
|
3.8
|
21.0
|
1.0
|
CA
|
B:GLN347
|
3.9
|
22.4
|
1.0
|
H
|
B:ASP293
|
4.0
|
15.0
|
1.0
|
N
|
B:GLY348
|
4.0
|
16.4
|
1.0
|
CG
|
B:ASP324
|
4.0
|
17.3
|
1.0
|
CA
|
B:ASP293
|
4.1
|
11.6
|
1.0
|
C
|
B:ASN294
|
4.1
|
22.9
|
1.0
|
CB
|
B:GLN347
|
4.2
|
23.5
|
1.0
|
N
|
B:GLY297
|
4.2
|
27.2
|
1.0
|
CA
|
B:GLY348
|
4.2
|
11.1
|
1.0
|
OD1
|
B:ASP293
|
4.3
|
2.0
|
1.0
|
HE22
|
B:GLN347
|
4.3
|
15.0
|
1.0
|
N
|
B:THR346
|
4.3
|
17.0
|
1.0
|
CB
|
B:ASP293
|
4.3
|
8.4
|
1.0
|
C
|
B:THR346
|
4.4
|
23.2
|
1.0
|
N
|
B:ASP293
|
4.5
|
16.2
|
1.0
|
CA
|
B:GLY297
|
4.5
|
21.3
|
1.0
|
OD1
|
B:ASP324
|
4.5
|
14.4
|
1.0
|
N
|
B:TRP295
|
4.5
|
24.9
|
1.0
|
O
|
B:ASN294
|
4.5
|
22.5
|
1.0
|
N
|
B:SER298
|
4.6
|
18.4
|
1.0
|
H
|
B:TRP295
|
4.6
|
15.0
|
1.0
|
CA
|
B:THR346
|
4.7
|
21.2
|
1.0
|
H
|
B:ASN294
|
4.7
|
15.0
|
1.0
|
CA
|
B:SER298
|
4.7
|
13.7
|
1.0
|
CG
|
B:ASP293
|
4.8
|
5.5
|
1.0
|
N
|
B:GLY345
|
4.9
|
19.6
|
1.0
|
H
|
B:GLY348
|
4.9
|
15.0
|
1.0
|
O
|
B:ARG344
|
4.9
|
16.4
|
1.0
|
CB
|
B:ASP324
|
5.0
|
15.8
|
1.0
|
|
Reference:
S.Singh,
M.J.Jedrzejas,
G.M.Air,
M.Luo,
W.G.Laver,
W.J.Brouillette.
Structure-Based Inhibitors of Influenza Virus Sialidase. A Benzoic Acid Lead with Novel Interaction. J.Med.Chem. V. 38 3217 1995.
ISSN: ISSN 0022-2623
PubMed: 7650674
DOI: 10.1021/JM00017A005
Page generated: Thu Jul 11 10:21:43 2024
|